2019
DOI: 10.1016/j.yexmp.2018.11.008
|View full text |Cite
|
Sign up to set email alerts
|

Molecular and cellular genetics of non-Hodgkin lymphoma: Diagnostic and prognostic implications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
14
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(15 citation statements)
references
References 64 publications
0
14
0
1
Order By: Relevance
“…In these cases, FISH or sequencing assessments of the cell population can indicate the diagnosis in addition to also having a prognostic value. These changes can be represented by Tumor protein p53 TP53 and cyclin-dependent kinase Inhibitor 2A CDKN2A mutations as markers of transformation [41], or can assist in differentiating between activated peripheral B-cell (ABC) and germinal center B-cell (GCB) types of DLBCL [42]. Moreover, certain translocations can be identified by FISH with the additional value of providing orientation in the diagnosis of a certain type of lymphoma [43].…”
Section: Discussionmentioning
confidence: 99%
“…In these cases, FISH or sequencing assessments of the cell population can indicate the diagnosis in addition to also having a prognostic value. These changes can be represented by Tumor protein p53 TP53 and cyclin-dependent kinase Inhibitor 2A CDKN2A mutations as markers of transformation [41], or can assist in differentiating between activated peripheral B-cell (ABC) and germinal center B-cell (GCB) types of DLBCL [42]. Moreover, certain translocations can be identified by FISH with the additional value of providing orientation in the diagnosis of a certain type of lymphoma [43].…”
Section: Discussionmentioning
confidence: 99%
“…Non-Hodgkin B-cell lymphomas (NHL) are the most common hematological malignancies worldwide and the fifth most common cancer. It is a heterogeneous group of lymphoid neoplasms, including latent types such as marginal-zone lymphomas (MZL), follicular lymphomas, and aggressive diseases such as diffuse large B-cell lymphoma (DLBCL) and Burkitt’s lymphoma, with complex etiopathology, a variety of symptomatology and clinical courses, and consequently different therapeutic approaches [ 1 ]. MZL are indolent diseases that arise from the small B cells of the marginal zone, which surrounds the lymph node and lies outside of the mantle zone.…”
Section: Introductionmentioning
confidence: 99%
“…2 The World Health Organization's (WHO) classification is currently the most used system. 3 The 2016 revision of the WHO classification includes the definition of more than 50 NHL types and a few temporary types. 4 Genital system involvement of non-Hodgkin lymphoma can be seen in two ways.…”
Section: Introductionmentioning
confidence: 99%